Using circulating tumour DNA to inform treatment strategy

Bookmark and Share
Published: 13 Nov 2015
Views: 1581
Dr Nitzan Rosenfeld - Cancer Research UK Cambridge Institute, Cambridge, UK

Dr Nitzan Rosenfeld talks to ecancertv at NCRI 2015 about his work looking at circulating tumour DNA as a quantitative measure of cancer burden and a way of monitoring a cancer's response to therapy.